Burgess L, Aldrighetti CM, Ghosh A, et al. Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer-specific mortality. JAMA Netw Open 2022;5:e2211869.

• PubMed
Burgess L, Aldrighetti CM, Ghosh A, Association of the USPSTF grade D recommendation against prostate-specific antigen screening with prostate cancer-specific mortality. JAMA Netw Open 2022;5:e2211869.)| false
• Search Google Scholar
• Export Citation

Timilshina N, Finelli A, Tomlinson G, et al. Applying quality indicators to examine quality of care during active surveillance in low-risk prostate cancer: a population-based study. J Natl Compr Canc Netw 2023;21:465–472.

• PubMed
Timilshina N, Finelli A, Tomlinson G, Applying quality indicators to examine quality of care during active surveillance in low-risk prostate cancer: a population-based study. J Natl Compr Canc Netw 2023;21:465–472.)| false
• Search Google Scholar
• Export Citation

Fastenau J, Jain K, Popovic A, Kovac E. Review of active surveillance in underrepresented and high-risk populations: feasibility and safety. Curr Urol Rep. Published online March 31, 2023. doi: 10.1007/s11934-023-01158-5

• PubMed
Fastenau J, Jain K, Popovic A, Kovac E. Review of active surveillance in underrepresented and high-risk populations: feasibility and safety. Curr Urol Rep. Published online March 31, 2023. doi: 10.1007/s11934-023-01158-5)| false
• Search Google Scholar
• Export Citation

Schneider AC, Chandrasekar T, Bowler N, et al. Impact of an expanded definition of family history on outcomes of active surveillance for prostate cancer. J Urol. Published online March 24, 2023. doi: 10.1097/ju.0000000000003396

• PubMed
Schneider AC, Chandrasekar T, Bowler N, Impact of an expanded definition of family history on outcomes of active surveillance for prostate cancer. J Urol. Published online March 24, 2023. doi: 10.1097/ju.0000000000003396)| false
• Search Google Scholar
• Export Citation

Ordner J, Flaifel A, Serrano A, et al. Significance of the percentage of Gleason pattern 4 at prostate biopsy in predicting adverse pathology on radical prostatectomy: application in active surveillance. Am J Clin Pathol. Published online March 11, 2023. doi: 10.1093/ajcp/aqad005

• PubMed
Ordner J, Flaifel A, Serrano A, Significance of the percentage of Gleason pattern 4 at prostate biopsy in predicting adverse pathology on radical prostatectomy: application in active surveillance. Am J Clin Pathol. Published online March 11, 2023. doi: 10.1093/ajcp/aqad005)| false
• Search Google Scholar
• Export Citation

Courtney PT, Deka R, Kotha NV, et al. Metastasis and mortality in men with low- and intermediate-risk prostate cancer on active surveillance. J Natl Compr Canc Netw 2022;20:151–159.

• PubMed
Courtney PT, Deka R, Kotha NV, Metastasis and mortality in men with low- and intermediate-risk prostate cancer on active surveillance. J Natl Compr Canc Netw 2022;20:151–159.)| false
• Search Google Scholar
• Export Citation

Lokeshwar SD, Syed JS, Segal D, et al. Optimal use of tumor-based molecular assays for localized prostate cancer. Curr Oncol Rep 2022;24:249–256.

• PubMed
Lokeshwar SD, Syed JS, Segal D, Optimal use of tumor-based molecular assays for localized prostate cancer. Curr Oncol Rep 2022;24:249–256.)| false
• Search Google Scholar
• Export Citation

Chamorro Castillo L, García Morales L, Ruiz López D, et al. The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice. Prostate. Published online March 11, 2023. doi: 10.1002/pros.24515

• PubMed
Chamorro Castillo L, García Morales L, Ruiz López D, The role of multiparametric magnetic resonance in active surveillance of a low-risk prostate cancer cohort from clinical practice. Prostate. Published online March 11, 2023. doi: 10.1002/pros.24515)| false
• Search Google Scholar
• Export Citation

Moore CM, King LE, Withington J, et al. Best current practice and research priorities in active surveillance for prostate cancer:-a report of a Movember International Consensus Meeting. Eur Urol Oncol 2023;6:160–182.

• PubMed
Moore CM, King LE, Withington J, Best current practice and research priorities in active surveillance for prostate cancer:-a report of a Movember International Consensus Meeting. Eur Urol Oncol 2023;6:160–182.)| false
• Search Google Scholar
• Export Citation

Oerther B, Engel H, Nedelcu A, et al. Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: performance of a fully automated AI-algorithm for lesion detection and classification. Prostate. Published online March 25, 2023. doi: 10.1002/pros.24528

• PubMed
Oerther B, Engel H, Nedelcu A, Prediction of upgrade to clinically significant prostate cancer in patients under active surveillance: performance of a fully automated AI-algorithm for lesion detection and classification. Prostate. Published online March 25, 2023. doi: 10.1002/pros.24528)| false
• Search Google Scholar
• Export Citation